Literature DB >> 2447045

Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.

H Nakashima1, O Yoshida, T S Tochikura, T Yoshida, T Mimura, Y Kido, Y Motoki, Y Kaneko, T Uryu, N Yamamoto.   

Abstract

The inhibitory effects of several polysaccharides, dextran, xylofuranan, and ribofuranan, and their sulfated counterparts on the infectivity and replication of human immunodeficiency virus (HIV) were examined by using an HTLV-I-carrying cell line, MT-4, in vitro. Dextran sulfate (Mw 34 X 10(3], xylofuranan sulfate, and ribofuranan sulfate completely prevented HIV-induced cytopathic effects (CPE) at concentrations greater than 10 micrograms/ml and dextran sulfate (Mw 7 X 10(3] at concentrations greater than 100 micrograms/ml. However, the non-sulfated compounds did not prevent them at any concentration tested. The anti-HIV effect of these polysaccharides was confirmed by measuring HIV-specific antigen expression in infected MT-4 cells. In cocultures with MOLT-4 and MOLT-4/HIVHTLV-IIIB cells, formation of multinucleated cells was completely inhibited in the presence of 100 micrograms/ml of these sulfated compounds. Dextran sulfate showed 20-30% growth inhibition of uninfected MT-4 cells at 1000 micrograms/ml but dextran sulfate, xylofuranan sulfate, and ribofuranan sulfate showed no effect on sulfated polysaccharides efficiently inhibited the reverse transcriptase activity of avian myeloblastosis virus and HIV.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447045

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  12 in total

1.  Evaluation of antiviral activity and toxicity of dextran sulfate in feline leukemia virus-infected cats.

Authors:  L E Mathes; K A Hayes; C L Swenson; P J Polas; S E Weisbrode; G J Kociba
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

2.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  In vitro screening of traditional medicines for anti-HIV activity: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

4.  Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection.

Authors:  Werner E G Müller; Xiaohong Wang; Meik Neufurth; Heinz C Schröder
Journal:  Prog Mol Subcell Biol       Date:  2022

5.  Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.

Authors:  H Nakashima; M Masuda; T Murakami; Y Koyanagi; A Matsumoto; N Fujii; N Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

6.  Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides.

Authors:  M E Busso; L Resnick
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

7.  Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine.

Authors:  A Shilatifard; R K Merkle; D E Helland; J L Welles; W A Haseltine; R D Cummings
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Rapid screening method with a cell multisizer for inhibitors of human immunodeficiency virus-induced cell fusion in vitro.

Authors:  H Nakashima; A Tanabe; T S Tochikura; N Yamamoto
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

9.  Anti-human immunodeficiency virus (HIV) drug HOE/BAY946 increases membrane hydrophobicity of human lymphocytes and specifically suppresses HIV-protein synthesis.

Authors:  L Biesert; M Adamski; G Zimmer; H Suhartono; J Fuchs; U Unkelbach; R J Mehlhorn; K Hideg; R Milbradt; H Rübsamen-Waigmann
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

10.  Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application.

Authors:  Koji Ichiyama; Sindhoora Bhargavi Gopala Reddy; Li Feng Zhang; Wei Xin Chin; Tegshi Muschin; Lars Heinig; Youichi Suzuki; Haraprasad Nanjundappa; Yoshiyuki Yoshinaka; Akihide Ryo; Nobuo Nomura; Eng Eong Ooi; Subhash G Vasudevan; Takashi Yoshida; Naoki Yamamoto
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.